Jia Li

Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy

B. Charbonnel, N. Iqbal, A. Barnett, 2013, Clinical Drug Investigation.

Combined therapy of GABA and sitagliptin prevents high-fat diet impairment of beta-cell function

G. Prud’homme, Y. Lou, Li Zhang, 2022, Molecular and Cellular Endocrinology.

Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis

Li Liu, Li Liu, Zhi-Chun Gu, 2022, Frontiers in Immunology.

CheckMate 9KD cohort A1 final analysis: Nivolumab (NIVO) + rucaparib for post-chemotherapy (CT) metastatic castration-resistant prostate cancer (mCRPC).

F. Saad, M. Burotto, D. Shaffer, 2021 .

Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone.

P. Hollander, E. Allen, Roland S. Chen, 2009, The Journal of clinical endocrinology and metabolism.

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

R. Frederich, P. Buchanan, Jia Li, 2014, BMC Endocrine Disorders.

Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial.

F. Saad, A. Armstrong, D. Shaffer, 2021, European journal of cancer.

Digital Commons@Becker Digital

F. Saad, A. Ravaud, A. Armstrong, 2023 .